Prostate Cancer Metastasis: Tracking and Targeting an Elusive Enemy

Speaker: Dr. Alison Allan
Original Date: Tuesday May 5, 2015
The majority of prostate cancer deaths are cause by the spread of tumour cells from the original prostate tumour to distant sites in the body, a process called metastasis. The ability to find, track and understand metastasis in cancer patients remains one of the greatest challenges in cancer treatment.

In this Expert Angle webinar Dr. Alison Allan describes the current knowledge about metastasis and the exciting developments in blood-based biomarker tests that may help find metastatic disease earlier and provide important information for effective, personalized treatment of prostate cancer.

Speaker – Dr. Alison Allan

15EGD-DrAllan.jpgDr. Alison Allan is a Senior Oncology Scientist and the Basic Science Co-Lead of the Metastasis Translational Cancer Research Team at the London Regional Cancer Program; and an Associate Professor of Oncology and Anatomy & Cell Biology at Western University in London, Ontario. Dr. Allan’s research program is focussed on cellular and molecular mechanisms of cancer metastasis; in particular the study of circulating tumour cells and cancer stem cells in patients and animal models. She has been the recipient of Prostate Cancer Canada research funding for her work in understanding circulating tumour cells in prostate cancer, and for the development of new blood-based biomarker tests to better track metastasis in prostate cancer patients.

Dr. Alison Allan can be reached at:

Cancer Research Laboratory Program
London Regional Cancer Program, London Health Sciences Centre
Victoria Research Labs, Room A4-132
London, Ontario
Canada N6A 4L6

Tel: 519.685.8600 Ext. 55134
Fax: 519.685.8616

About Expert Angle

Expert AngleExpert Angle is designed to expand our reach and address the many varied and complex questions that come with a prostate cancer diagnosis. These webinars will address topics important to men with prostate cancer along different points of the cancer care continuum and those within their circle of care as well as the general public and representatives from the clinical community.
The meetings are hosted using interactive on-line technology and feature leading experts in prostate cancer - making them accessible to anyone, regardless of their location, within Canada. The platform allows PCC to communicate directly with individuals in a variety of settings (i.e. in their homes, support group meetings, community centres) and geographic locations (i.e. urban, rural and remote locations) as well as measure engagement.   

View more Expert Angle webinars.


Donate Now!

Subscribe to our free monthly e-newsletter!

* indicates required


PCC Spotlight
Rock the Road Raffle returns with its most valuable car to date

A 2018 Acura NSX to be prized by Prostate Cancer Canada and TADA at the AutoShow  

Prostate Cancer Canada and the Movember Foundation Announce $4M in Research Grants

Toronto, October 23, 2018 – Prostate Cancer Canada and the Movember Foundation today announced $4 million in funding to three Canadian researchers to predict how well prostate cancer will respond to treatment, based on men’s biological markers, specifically in their tumour cells and blood – opening a path to more personalized care with fewer side effects and a better chance of survival.

Gay and bisexual men living with prostate cancer focus of research

Vancouver, September 25, 2018 – Research funded by Prostate Cancer Canada is preparing the way to improve quality of life for men-who-have-sex-with-men (MSM)1 in the LGBTQ2+ community.

Click here for news archive